SEC Filings

10-Q
ARRAY BIOPHARMA INC filed this Form 10-Q on 05/10/2017
Entire Document
 

ARRAY BIOPHARMA INC.
Condensed Statement of Stockholders' Equity (Deficit)
(In thousands)
(Unaudited)

 
 
 
 
 
Additional Paid-in Capital
 
Accumulated Other Comprehensive Income
 
Accumulated Deficit
 
Total
 
Common Stock
 
 
 
 
 
Shares
 
Amounts
 
 
 
 
Balance as of June 30, 2016
143,690

 
$
144

 
$
763,324

 
$
7

 
$
(801,407
)
 
$
(37,932
)
Shares issued for cash under employee share plans, net
729

 
1

 
2,297

 

 

 
2,298

Employee share-based compensation expense

 

 
6,898

 

 

 
6,898

Cumulative effect adjustment upon adoption of ASU 2016-09

 

 
436

 

 
(436
)
 

Issuance of common stock, net of offering costs / Public offering
21,160

 
21

 
124,171

 

 

 
124,192

Issuance of common stock, net of offering costs / At-the-market offering
4,318

 
4

 
19,573

 

 

 
19,577

Change in unrealized loss on marketable securities

 

 

 
(93
)
 

 
(93
)
Net loss

 

 

 

 
(87,226
)
 
(87,226
)
Balance as of March 31, 2017
169,897

 
$
170

 
$
916,699

 
$
(86
)
 
$
(889,069
)
 
$
27,714

 
The accompanying notes are an integral part of these unaudited condensed financial statements.


5